Merck & Co (MRK)
$126.45
0.60 (0.48%)
MRK Stock Quote Delayed 30 Minutes
3 New Buys for November – ADS CLB TM
The government is open again, the Fed will continue easing, and a strong period for the markets is ahead. Here are our 3 new buys to help you profit
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
320.09B
PE Ratio
140.50
EPS
0.9
Volume (Avg. Vol.)
6.79M
Day's Range
$124.91 - $126.60
52-Week Range
$99.14 - $134.63
Dividend & Yield
$2.92 (2.31%)
MRK Stock Predictions, Articles, and Merck & Co News
5 Dividend Darlings to Dump Now
All dividend stocks are not created equal, and some companies with nice yields could still pose a big risk to your portfolio.
3 Pharma Stocks Just Running in Place
Gobs of free cash flow doesn't mean a company is worth buying. Some companies, especially pharmaceuticals, just use cash to run in place.
Should I Buy Zoetis? 3 Pros, 3 Cons
Animal medicines stock Zoetis has basically been treading water since its IPO. Is it a potential boomer in the making, or should you expect more flat going forward?
3 Healthcare Stocks With Healthy Dividends
Protect yourself from the headwinds facing healthcare stocks by snatching up names that offer -- and are likely to keep offering -- big-time dividends.
Pfizer & Merck: Dividend Winners or Duds?
Pfizer and Merck got addicted to Lipitor and Singulair, and now slumping sales of the former blockbusters have both companies scrambling for growth.
3 Funds to Play the Healthcare Megatrend
Healthcare has been hot in 2013, but more importantly, it's set up to be a huge mover going forward thanks to several big trends. Here's how to get your piece.
5 Megatrend Plays Offering Big Payouts
Megatrend investments usually require years if not decades to play out, but these five particular stocks offer investors some sizable income for waiting.
The Top 10 Dow Dividend Stocks for June
With so much uncertainty out there, investors could do a lot worse than buying into these venerable blue chips -- especially the reigning king of big payouts.
Pharma, Tech Drive the Dow: Monday’s IP Market Recap
markets managed to start out the new month on a up note, as pharmaceuticals and technology companies shined during a broad-based rally
Should I Buy Pfizer? 3 Pros, 3 Cons
Pfizer's Q4 earnings put a small scare into investors a couple weeks back, but the pharma behemoth is built too well to ignore.
10 Defensive Stocks Taking on Some Froth
Defensive stocks have been on fire and outpacing the broader market for months. However, while many still offer enticing yields, you'll be overpaying by jumping in now.
3 Pharma Stocks to Buy Into Earnings
We'll learn a lot about healthcare names over the course of this earnings season -- I'm expecting big things from these three drugmakers.
Healthcare Stocks: The Market’s Latest Untouchable Sector
The healthcare sector has delivered outstanding year-to-date returns, but investors need to be aware how much of the performance is the result of macro trends.
Apple Is a Strong Buy But Keep an Eye on The Price
Apple's fall from grace happens because its a non-correlated stock that doesn't behave in step with the greater markets. Now may be a good time to get back in.
An HIV ‘Cure’? Let’s Not Overstate the Success
Merck, J&J and others won't be dropping their research to recreate the success seen in the early treatment of an HIV-positive child.
Newborn Cured of HIV
A little girl in Mississippi, who was born infected with HIV, was apparently cured of the disease after receiving a three drug cocktail shortly after birth.
Should I Buy Merck? 3 Pros, 3 Cons
Merck is in the midst of a prolonged downtrend after hitting multiyear highs in 2012. Should you get in, or keep avoiding the Big Pharma stock?
2 Newer Names for Retirement Income
If you’re a retiree who needs income for living expenses, consider these new closed-end funds yielding more than 7%.
